| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |